Managed Clinical Network for esophageal cancer enables reduction of variation between hospitals trends in treatment strategies, lead time, and 2-year survival

Autor: Jolanda C. van Hoeve, Rob H.A. Verhoeven, Wouter B. Nagengast, Vera Oppedijk, Mitchell G. Lynch, Johan M. van Rooijen, Patrick Veldhuis, Sabine Siesling, Ewout A. Kouwenhoven

Publikováno v: European journal of surgical oncology, 48(1), 106-112. Elsevier
European Journal of Surgical Oncology, 49(1), 106-112. W.B. Saunders Ltd
European Journal of Surgical Oncology, 49(1), 106-112. ELSEVIER SCI LTD
European journal of surgical oncology, 49(1), 106-112. W.B. Saunders Ltd
van Hoeve, J C, Verhoeven, R H A, Nagengast, W B, Oppedijk, V, Lynch, M G, van Rooijen, J M, Veldhuis, P, Siesling, S & Kouwenhoven, E A 2023, ' Managed Clinical Network for esophageal cancer enables reduction of variation between hospitals trends in treatment strategies, lead time, and 2-year survival ', European Journal of Surgical Oncology, vol. 49, no. 1, pp. 106-112 . https://doi.org/10.1016/j.ejso.2022.07.022

Introduction: Despite evidence-based guidelines, variation in esophageal cancer care exists in daily practice. Many oncology networks deployed regional agreements to standardize the patient care pathway and reduce unwarranted clinical variation. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d357e2eed83f327ff14ab7dbd8fa6ad8
https://research.utwente.nl/en/publications/736c31c5-6e9d-4f18-9ad7-887b41449254